Claims
- 1. A pharmaceutical composition comprising the crude extract of Cistanche deserticola Y.C. MA as an active ingredient for the treatment and prevention of degenerative brain disease.
- 2. The pharmaceutical composition according to claim 1 wherein said crude extract is extracted with the solvent selected from the group consisting of water, lower alcohol and the mixture thereof.
- 3. The pharmaceutical composition according to claim 2 wherein said lower alcohol is methanol.
- 4. A pharmaceutical composition comprising the polar solvent soluble extract of Cistanche deserticola Y.C. MA as an active ingredient for the treatment and prevention of degenerative brain disease.
- 5. The pharmaceutical composition according to claim 4 wherein said polar solvent soluble extract is extracted with the solvent selected from the group consisting of water, lower alcohol and the mixture thereof.
- 6. The pharmaceutical composition according to claim 5 wherein said lower alcohol is butanol.
- 7. A pharmaceutical composition comprising the non-polar solvent soluble extract of Cistanche deserticola Y.C. MA as an active ingredient for the treatment and prevention of degenerative brain disease.
- 8. The pharmaceutical composition according to claim 7 wherein said non-polar solvent is selected at least one from the group consisting of hexane, carbon tetrachloride, chloroform, methylene chloride, ethyl ether and ethyl acetate.
- 9. The pharmaceutical composition according to claim 8 wherein said nonpolar solvent is ethyl acetate.
- 10. The pharmaceutical composition according to claim 1 wherein said extract is extracted from the plant consisting of Cistanche deserticola, C. salsa, C. ambigua or and the same genus plant.
- 11. The pharmaceutical composition according to claim 1 wherein said degenerative brain disease comprises stroke, Alzheimer's disease (AD), Parkinson's disease (PD), senile dementia.
- 12. The pharmaceutical composition according to claim 1 wherein said composition is containing the extract between 0.1 to 50% by weight based on the total weight of the composition.
- 13. A use of a crude extract, polar solvent soluble or non-polar solvent soluble extract of Cistanche deserticola Y.C. MA for the preparation of therapeutic agent for the treatment and prevention of degenerative brain disease.
- 14. A health food comprising the crude extract of Cistanche deserticola Y.C. MA, together with a sitologically acceptable additive for the prevention and improvement of degenerative brain disease.
- 15. The health food according to claim 14 wherein said health food is provided as powder, granule, tablet, chewing tablet, capsule or beverage type.
Priority Claims (1)
Number |
Date |
Country |
Kind |
10-2002-0047412 |
Aug 2002 |
KR |
|
CROSS REFERENCE TO RELATED APPLICATION
[0001] This application is a continuation patent application of PCT Patent Application No. PCT/KR03/1622, which was filed on Aug. 12, 2004, designating the United Stares of America, now abandoned.
Continuations (1)
|
Number |
Date |
Country |
Parent |
PCT/KR03/01622 |
Aug 2003 |
US |
Child |
10854203 |
May 2004 |
US |